Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction Note: Autoantibodies detection in patients affected by autoimmune retinopathies.
Ceccarini MR, Medori MC, Dhuli K, Tezzele S, Bonetti G, Micheletti C, Maltese PE, Cecchin S, Donato K, Colombo L, Rossetti L, Staurenghi G, Salvetti AP, Oldani M, Ziccardi L, Marangoni D, Iarossi G, Falsini B, Placidi G, D'Esposito F, Viola F, Nassisi M, Leone G, Cimino L, De Simone L, Mastrofilippo V, Beccari T, Bertelli M. Ceccarini MR, et al. Among authors: staurenghi g. Eur Rev Med Pharmacol Sci. 2024 May;28(9):3293. doi: 10.26355/eurrev_202405_36203. Eur Rev Med Pharmacol Sci. 2024. PMID: 38766784 Free article.
Autoantibodies detection in patients affected by autoimmune retinopathies.
Ceccarini MR, Medori MC, Dhuli K, Tezzele S, Bonetti G, Micheletti C, Maltese PE, Cecchin S, Donato K, Colombo L, Rossetti L, Staurenghi G, Salvetti AP, Oldani M, Ziccardi L, Marangoni D, Iarossi G, Falsini B, Placidi G, D'Esposito F, Viola F, Nassisi M, Leone G, Cimino L, De Simone L, Mastrofilippo V, Beccari T, Bertelli M. Ceccarini MR, et al. Among authors: staurenghi g. Eur Rev Med Pharmacol Sci. 2023 Dec;27(6 Suppl):57-63. doi: 10.26355/eurrev_202312_34690. Eur Rev Med Pharmacol Sci. 2023. PMID: 38112948 Free article.
Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice.
Testa F, Bacci G, Falsini B, Iarossi G, Melillo P, Mucciolo DP, Murro V, Salvetti AP, Sodi A, Staurenghi G, Simonelli F. Testa F, et al. Among authors: staurenghi g. Eye (Lond). 2024 Apr 16. doi: 10.1038/s41433-024-03065-6. Online ahead of print. Eye (Lond). 2024. PMID: 38627549 Review.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Immunomodulatory Treatment Versus Systemic Steroids in Inflammatory Choroidal Neovascularization Secondary to Idiopathic Multifocal Choroiditis.
Airaldi M, Monteduro D, Tondini G, Pichi F, De Simone L, Cornish E, Casalino G, Zicarelli F, Oldani M, Staurenghi G, McCluskey P, Cimino L, Invernizzi A. Airaldi M, et al. Among authors: staurenghi g. Am J Ophthalmol. 2024 Jun;262:62-72. doi: 10.1016/j.ajo.2024.01.006. Epub 2024 Jan 14. Am J Ophthalmol. 2024. PMID: 38224927 Free article.
Reply.
Romano F, Zaffalon C, Staurenghi G, Salvetti AP. Romano F, et al. Among authors: staurenghi g. Ophthalmology. 2024 Apr;131(4):e15-e16. doi: 10.1016/j.ophtha.2023.11.029. Epub 2024 Jan 9. Ophthalmology. 2024. PMID: 38206214 No abstract available.
323 results